Results 31 to 40 of about 11,697 (224)

Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion

open access: yesBrazilian Journal of Medical and Biological Research, 2014
The mechanisms of statins relieving the no-reflow phenomenon and the effects of single-dose statins on it are not well known. This study sought to investigate the effects of inflammation on the no-reflow phenomenon in a rabbit model of acute myocardial ...
X.J. Zhao, X.L. Liu, G.X. He, H.P. Xu
doaj   +1 more source

Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention

open access: yesJournal of Tehran University Heart Center, 2018
Background: Despite recent advances in interventional equipment and techniques, the angiographic no-reflow phenomenon occurs in a considerable number of patients undergoing primary percutaneous coronary intervention (PCI).
Mohammad Alidoosti   +6 more
doaj   +1 more source

No reflow phenomenon in CAD patients after percutaneous coronary intervention: A prospective hospital based observational study

open access: yesIndian Heart Journal, 2023
The present study assessed incidence, risk factors, in-hospital and short-term outcomes associated with no-reflow in patients undergoing percutaneous coronary intervention (PCI) in STEMI, NSTEMI, unstable angina and stable angina. Out of 449 patients, 42
Shivani Rao   +3 more
doaj   +1 more source

Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization [PDF]

open access: yes, 2006
AIMS: No-reflow after a primary percutaneous coronary intervention (PCI) is associated with a high incidence of left ventricular (LV) failure and a poor prognosis.
Trani C.   +34 more
core   +1 more source

Prevalence and Predictors of No-Reflow Phenomenon in Patients with Acute Coronary Syndrome in Slemani Cardiac Hospital

open access: yesAdvanced Medical Journal
Background and objectives: Understanding factors linked to the no-reflow phenomenon after percutaneous coronary intervention in acute coronary syndromes is important for optimizing reperfusion strategies.
Binar Yadgar Raouf Heshmet   +2 more
doaj   +1 more source

Clinical, Laboratory, and Procedural Predictors of No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention

open access: yesJournal of Tehran University Heart Center, 2020
Background: No-reflow is a major challenging issue in the management of patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).
Maryam Shakiba   +4 more
doaj   +1 more source

Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction. [PDF]

open access: yesPLoS ONE, 2015
To study the mechanism of the no-reflow phenomenon using coronary angiography (CAG) and intravascular ultrasound (IVUS).A total of 120 patients with acute myocardial infarction (AMI) who successfully underwent indwelling intracoronary stent placement by ...
Junxia Li   +4 more
doaj   +1 more source

The Relationship Between The Level Of Serum Uric Acid And No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention İn Patients With St Segment Elevated Myocardial Infarction [PDF]

open access: yesDüzce Tıp Fakültesi Dergisi, 2010
No-reflow phenomenon is the absence of myocardial perfusion despite adequate dilatation ofthe infarct related coronary artery during percutaneous coronary intervention.
İsmail ERDEN, Emine Çakcak ERDEN, Serhat Bahadır SÖZEN, Osman Kayapınar, Sabri Onur ÇAĞLAR, Cengiz BAŞAR
doaj  

Lipidomic Predictors of Coronary No-Reflow

open access: yes, 2023
The ‘no-reflow’ phenomenon (NRP) after primary percutaneous coronary intervention (PCI) is a serious complication among acute ST-segment elevation myocardial infarction (STEMI) patients. Herein, a comprehensive lipidomics approach was used to
Singal, Pawan K.   +15 more
core   +1 more source

CHA2DS2 VASc score and brachial artery flow-mediated dilation as predictors for no-reflow phenomenon in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

open access: yesThe Egyptian Heart Journal, 2022
Background Following primary percutaneous coronary intervention (PCI), no-reflow is associated with a high rate of long-term unfavorable clinical outcomes.
Mohamed Ismail Rashed   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy